H. J. Yousuf ( )
P. Baillie ( )
January 2004, Volume 54, Issue 1
Case Reports
Introduction
Case Report
Semen analysis of her husband showed a total count of 915 million, the morphology showing 45% normal forms and a motility of 70 percent (61% rapid linear progression).
Special tests revealed positive anti-nuclear antibodies and anti-phospholipid antibody IgM levels of 15.6 m.i.u. per litre. Dispirin 75mg daily resulted in normalization on re-testing.
The process of in vitro fertilization was started with gonadotrophin releasing hormone agonist (GnRHa) on day 21 of the cycle. No period resulted and a plasma ßHCG on day 30 was 153 iu/litre, diagnostic of pregnancy. The IVF cycle was stopped. The pregnancy progressed uneventfully and a normal male baby weighing 6 pounds 9 ounces was delivered by caesarean section for failure to progress in labour at 39 weeks of gestation.
Discussion
Confirmation of pregnancy is usually carried out by means of a urinary immunological pregnancy test. These are designed to detect a pregnancy within 3 days of delayed menstruation. Nevertheless, false positive results are due to improperly stored test kits, marked proteinuria and contamination with a vaginal discharge. False negative results can also occur with dilute urine (S.G. <1.015) and drug interactions.
More reliable results are obtained by measuring serum ßHCG, although even this is not absolute due to variation in standards.3
The occurrence of pregnancy coinciding with luteal use of a gonadotrophin releasing hormone agonist for down regulation of ovarian function prior to in-vitro fertilization is noteworthy because of the prolonged infertility. It is plausible that the early flare of increased gonadotrophins (mainly LH)4 may have improved luteal function and hence assisted in continuation of pregnancy.5,6
References
2. Hull M, Glazener C, Kelly N. Population study of causes, treatment and outcome of infertility. BMJ 1985;291:1693-7.
3. ACOG practice bulletin Number 3, December 1998. Medical management of tubal pregnancy. Quantification of hCG complicated by 3 different referral standards.
4. Keisel LA, Rody A, Greb RR, et al. Clinical use of GnRH analogues. Clin Endocrinol 2002;56:677-87.
5. Wilshire G, Emmi A, Gagliardi C, et al. Gonadotrophin releasing hormone agonist administration in early pregnancy is associated with normal outcomes. Fertil Steril 1993;60:980-3.
6. Platteau P, Gabbie M, Talbot M, et al. Two consecutive pregnancies during inadvertent GnRH desensitization. Fertil Steril 2000;73:1244-6.
Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: